Market Cap
NaN
52 Wk Range
$ - $
Previous Close
$N/A
Open
$N/A
Day Range
N/A - N/A
Volume
N/A
Avg Volume
N/A
Enterprise Value
6.904M
Cash
5.792M
Avg Qtr Burn
-5.869M
Short % of Float
3.73%
Insider Ownership
16.31%
Institutional Own.
17.68%
Qtr Updated
10/31/24
Drug Pipeline
Powered by

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
Drug & Indication | Stage & Event | Catalyst Date |
---|---|---|
Bria-IMT™ (SV-BR-1-GM) Details Cancer, Breast cancer | Phase 3 Data readout | |
Bria-OTS™ + tislelizumab Details Breast cancer, Cancer | Phase 1/2 Data readout | |
Bria-PROS+ Details Cancer, Prostate cancer | IND Submission |